ADCETRIS (brentuximab vedotin)

ADCETRIS® (brentuximab vedotin)

Seattle Genetics has U.S. and Canadian commercialization rights to ADCETRIS. Click here to visit the company's website.

US Healthcare Providers
Visit the Product Website for details and download the full Prescribing Information (PDF).

Ex-US Healthcare Providers
Please view the European Summary of Product Characteristics (PDF) for details. The prescribing information in your country may vary; please consult your local prescribing information.